-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Y-mAbs Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2019 to Q1 2024.
- Y-mAbs Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $159K, a 12.6% decline year-over-year.
- Y-mAbs Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $735K, a 12.4% decline from 2022.
- Y-mAbs Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $839K, a 7.29% increase from 2021.
- Y-mAbs Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $782K, a 97.5% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)